Ship Healthcare Holdings stock forecast
Ship Healthcare Holdings (5EZ) Stock Forecast & Price Target
5EZ Analyst Ratings
5EZ Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| UBS | €14.48→€16.47 | hold | 13.59%Upside | Reiterated | 02/16/26 | |||
| Kyoichiro Shigemura | Nomura | €22.60 | buy | 55.89%Upside | Reiterated | 02/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| HoldReiterated€14.48→€16.47 | 02/16/26 | 13.59%Upside | |||
| Kyoichiro ShigemuraNomura | BuyReiterated€22.60 | 02/12/26 | 55.89%Upside |
Best Analysts Covering Ship Healthcare Holdings
Copying Kyoichiro Shigemura's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.72% per trade.
Copying Kyoichiro Shigemura's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +17.48% per trade.
Copying Kyoichiro Shigemura's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +15.97% per trade.
5EZ Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 5EZ has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 5EZ average Analyst price target in the past 3 months is ―.
5EZ Financial Forecast
5EZ Earnings Forecast
Next quarter’s earnings estimate for 5EZ is EUR 0.21 with a range of EUR 0.21 to EUR 0.21. The previous quarter’s EPS was EUR 0.25. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
5EZ Sales Forecast
Next quarter’s sales forecast for 5EZ is EUR 1.05B with a range of EUR 1.04B to EUR 1.06B. The previous quarter’s sales results were EUR 1.05B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

